论文部分内容阅读
作者回顾性分析了澳大利亚与新西兰10个肿瘤放疗中心淋巴瘤协作组(AROLG)1969年1月～1988年12月单独放疗820例膈上淋巴结型早期何杰金氏病(EHD)的疗效,随诊2～22年。5年内失随69例,10年内失随131例,1例死于开腹术。中位年龄29岁(2～84岁),男437例,女383例,按Ann Arbor系统临床分期(CS)310例,I_A170例(55％),Ⅰ_B5例(2％),Ⅱ_A135例(43％)。剖腹探查病理分期(PS)510例,Ⅰ_A214例(42％),Ⅰ_B13例(3％),Ⅱ_A283例(55％)。疗前测ESR47％,胸片99％,骨髓徐片90％,胸/腹
The authors retrospectively analyzed the efficacy of 820 cases of early supraorbital lymph node type early Hodgkin’s disease (EHD) in 10 tumor radiotherapy collaborators (AROLG) from January 1969 to December 1988 in Australia and New Zealand. Diagnosis 2-22 years. 69 cases were lost within 5 years, 131 cases were lost within 10 years, and 1 case died of laparotomy. The median age was 29 years (range, 2 to 84 years), male 437, female 383, according to the Ann Arbor system clinical stage (CS) 310 cases, I_A170 cases (55%), I_B 5 cases (2%), II_A135 cases (43 %). There were 510 cases of pathological staging (PS), 121 cases (42%) of I_A, 13 cases (3%) of I_B, and 2_A283 cases (55%). Pre-test ESR 47%, Chest 99%, Bone Marrow 90%, Chest/Abdomen